Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1989

Incidence and Clinicopathologic Features of Primary Lung Cancer: A North-Eastern Anatolia Region Study in Turkey (2006-2012)  

Demirci, Elif (Department of Pathology, Medical Faculty, Ataturk University)
Daloglu, Ferah (Department of Pathology, Medical Faculty, Ataturk University)
Gundogdu, Cemal (Department of Pathology, Medical Faculty, Ataturk University)
Calik, Muhammet (Department of Pathology, Medical Faculty, Ataturk University)
Sipal, Sare (Department of Pathology, Medical Faculty, Ataturk University)
Akgun, Metin (Department of Chest Disease, Medical Faculty, Ataturk University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1989-1993 More about this Journal
Abstract
Background: Lung cancer is the most frequent cancer among men and second highest among women overall, including in Turkey. Cigarette smoking is the most important etiologic factor for the development of cancer in both men and women. Objective: To determine the lung cancer incidence in Northeastern Anatolia Region of Turkey with a focus on clinical properties, cancer subtypes, the relationships of tumors with cigarette smoking and radiological properties of the lesions. Materials and Methods: In a retrospective study design, 566 lung cancer cases diagnosed at the Pathology Department of Ataturk University in Erzurum over the last seven years extending from January 2006 to June 2012 were investigated. The results were compared with statistical analyses. Results: The most common histopathological subtype of primary bronchogenic carcinoma in our study was found to be the squamous cell carcinoma, 46.1% (261 out of 566), and the second was small cell lung carcinoma 15.7% (89 out of 566). Based on our data, an overall male predominance was noted with a male/female ratio of 6.1/1. While 296 (52.2%) of the patients were found to be smokers at the time of diagnosis, 125 (22.0%) were nonsmokers and 145 (25.6%) were ex-smokers. Smoking status was found to have a strong correlation with primary lung cancer (p<0.05), and there were significant differences between males and females (p<0.001). Conclusion: Although relative prominence of subtypes of lung cancers differ between Turkish and other populations, lung cancer overall remains as an important health problem in Turkey. Our findings stress the critical need for effective cancer prevention programs such as anti-smoking campaigns.
Keywords
Lung cancer; histopathology; incidence data; smoking;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Santos-Martines MJ, Curull V, Blanco ML et al (2005). Lung cancer at a universiy hospital: epidemiological and histological characteristics of a recent and a historical series. Arch Bronconeumol, 41, 307-12.
2 Simonato L, Agudo A, Ahrens W, et al (2001). Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer, 91, 876-87.   DOI   ScienceOn
3 Tacha D, Yu C, Bremer R, Oi W, Haas T (2012). A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma. Appl Immunohistochem Mol Morphol, 20, 201-7.   DOI   ScienceOn
4 Thun MJ, Lally CA, Flannery JT et al (1997). Cigarette smoking and changes in the hispathology of lung cancer. J Natl Cancer Inst, 89, 1580-6.   DOI   ScienceOn
5 Travis WD, Brambilla E, Noguchi M, et al (2011). International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 6, 244-85.   DOI   ScienceOn
6 Travis WD, Travis LB, Devesa SS (1995). Lung cancer. Cancer, 75, 191-202.   DOI   ScienceOn
7 Turner B, Cagle P, Sainz I, et al (2012). Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and pecific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma:evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med, 136, 163-71.   DOI   ScienceOn
8 WHO (1997). Tobacco or health: a global status report. Geneva, Switzerland: world health organization.
9 Yurdakul AS, calisir HC, Demirag F, Taci N, ogretensoy (2002). Akciger kanserinin histolojik tiplerinin dagilimi; 2216 olgunun analizi. Toraks Dergisi, 1, 59-65.
10 Bozkurt B, Selcuk ZT, Firat P, Kalyoncu AF, Artvinli M (2004). 1972-2002 doneminde Hacettepe universitesi Tip Fakultesi Hastanesi'nde akciger kanseri tanisi konulan hastalarin histolojik ve epidemiyolojik degerlendirmesi. Toraks Dergisi, 5, 148-53.
11 Bryant A, Cerfolio RJ (2007). Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest, 132, 185-92.   DOI   ScienceOn
12 Charloux A, Quoix E, Wolkove N, et al (1997). The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol, 26, 14-23.   DOI   ScienceOn
13 Cox JD, Yesner RA (1979). Adenocarcinoma of the lung: recent results from the veterans administration lung group. Am Rev Respir Dis, 120, 1025-9.
14 De Geer A, Eriksson J, Finnern HW (2013). A cross- country review of data collected on non- small cell lung cancer (NSCLC) patients in cancer registeries, databases, retrospective and non-randomized prospective studies. J Med Economics, 16, 134-49.   DOI   ScienceOn
15 Dey A, Biswas D, Saha SK, Kundu S, Sengupa A (2012). Comparison study of clinicoradiological profile of primary lung cancer cases: An Eastern India experience. Indian J Cancer, 49, 89-95.   DOI
16 Gunbatar H, Sertogullarindan B, ozbay B, Sunnetcioglu A, Ekin S (2012). Akciger kanserli olgularin degerlendirilmesi; 3 yillik analiz. Van Tip Dergisi, 19, 13-20.
17 Hsu CL, Chen KY, Shih JY, et al (2012). Advanced non-small lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer, 12, 241.   DOI
18 Missaoui1N, Hmissal S, Landolsi1 H et al (2011). Lung Cancer in Central Tunisia: Epidemiology and Clinicopathological Features. Asian Pac J Cancer Prev, 12, 2305-9.
19 İtil O (2000). Akciger kanserlerinin epidemiyolojisi ve etyolojisi In: 'Akciger kanserleri: Tani ve tedavi', Ed Haydaroglu A. EgeUniversitesi Basimevi, Izmir pp 15-34.
20 Kanematsu T, Hanibuchi M, Tomimoto H, et al (2010). Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan. J Med Investigation, 57, 327-33.
21 Navani N, Brown J M, Nankivell M, et al (2012). Suitability of EBUS- TBNA specimens for subtyping and genotyping of NSCLC: a multi-center study of 774 patients. Am J Respir Crit Care Med, 185, 1316-22.   DOI   ScienceOn
22 Parkin DM, Muir CS (1992). Cancer Incidence in Five Continents. IARC Scientific Publication No.120. Lyon: IARC. pp 45-173.
23 Salim EI, Jazieh AR, Moore MA (2011). Lung cancer incidence in the Arab League countries: risk factors and control. Asian Pac J Cancer Prev, 12, 17-34.
24 Arinc S, Ertugrul M, Salturk C, et al (2007). Primer akciger kanserinde bronkoskopi bulgularinin sigara aliskanligi ile iliskisi. Toraks Dergisi, 8, 6-9.
25 Atici AG, Erkan L, Findik S, Uzun O, Kandemir B (2004). Kucuk hucreli disi akciger kanserli hastalarin klinik ozellikleri. Tuberkuloz ve Toraks Dergisi, 52, 150-8.
26 Alpar S, Ucar N, Agackiran Y, et al (2004). Akciger kanserlerinin histopatolojik ve morfolojik ozellikleri ile bronsiyal yerlesimleri arasindaki iliskinin degerlendirilmesi. Solunum Hastaliklari, 15, 127-31
27 Araz O, Akgun M, Gorguner M (2010). Lung Cancer Incidence in Erzurum City. EAJM, 42, 111-5   DOI   ScienceOn